Overview on Hepatitis B vaccination | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 112, Volume 86, Issue 1, January 2022, Page 696-699 PDF (619.35 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2022.215573 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mona Ali Saber  ; Hatem Abdul-Monsef Sarhan; Yasser Mahrous Fouad; Mahmoud MA Elsayed; Alshymaa Ahmed Hassnine
| ||||
| Abstract | ||||
| Background: Hepatitis B virus (HBV) infection is increasing globally, posing a serious public health problem. Hepatitis B virus (HBV) infection and mortality are among the leading causes of death worldwide. Concerns for public health are amplified by the fact that about a third of the world's population is afflicted with HBV. HBV infection may result in cirrhosis, hepatocellular cancer, or both (HCC). Immunization is the most cost-effective strategy available worldwide for controlling and preventing hepatitis B in terms of benefit-cost ratio. Objective: This review article discusses the most critical components of the HBV vaccine and the most efficient strategies for increasing HBV vaccination. | ||||
| Keywords | ||||
| Antibodies; HBs-antigen; Hepatitis B vaccine; Hepatitis B virus; Immunizat | ||||
|
Statistics Article View: 294 PDF Download: 289 |
||||
